Wealth Enhancement Advisory Services’s Century Therapeutics IPSC Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$175K	Buy	77,830 +33	+0%	+$75	﹤0.01%	3635
2026 Q1	$166K	Hold	77,797	–	–	﹤0.01%	3201
2025 Q4	$70K	Sell	77,797 -56	-0.1%	-$34	﹤0.01%	3496
2025 Q3	$43.5K	Sell	77,853 -3,394	-4%	-$1.83K	﹤0.01%	3444
2025 Q2	$45.1K	Sell	81,247 -3,836	-5%	-$2.06K	﹤0.01%	3238
2025 Q1	$40.5K	Buy	85,083 +6,430	+8%	+$4.83K	﹤0.01%	2865
2024 Q4	$79.4K	Buy	78,653 +443	+0.6%	+$603	﹤0.01%	2828
2024 Q3	$134K	Sell	78,210 -24	-0%	-$47	﹤0.01%	2508
2024 Q2	$199K	Buy	78,234 +19	+0%	+$60	﹤0.01%	2303
2024 Q1	$327K	Hold	78,215	–	–	﹤0.01%	1863
2023 Q4	$260K	Buy	78,215 +48,064	+159%	+$87.6K	﹤0.01%	1913
2023 Q3	$60.3K	Buy	+30,151	New	+$80.2K	﹤0.01%	2146

Other funds holding IPSC

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

MFG

Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Wealth Enhancement Advisory Services's IPSC Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Century Therapeutics (IPSC) stake by 0.04% in Q2 2026, buying an estimated $75 and bringing the position to 77,830 shares worth $175K. The position accounts for ﹤0.01% of the portfolio, ranked #3635.

Wealth Enhancement Advisory Services first reported a position in IPSC in Q3 2023 and has held it in 12 quarters since. The position peaked at $327K in Q1 2024. 6 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

Wealth Enhancement Advisory Services held 77,830 shares of Century Therapeutics worth $175K as of Q2 2026.
Wealth Enhancement Advisory Services bought 33 Century Therapeutics shares in Q2 2026, an estimated $75.
Century Therapeutics made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3635 holding.
Wealth Enhancement Advisory Services first reported a position in Century Therapeutics in Q3 2023 and has held it in 12 quarters since.
Wealth Enhancement Advisory Services's Century Therapeutics position peaked at $327K in Q1 2024.
6 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.